These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 32360306)

  • 1. Development of tissue factor-targeted liposomes for effective drug delivery to stroma-rich tumors.
    Shimizu K; Takeuchi Y; Otsuka K; Mori T; Narita Y; Takasugi S; Magata Y; Matsumura Y; Oku N
    J Control Release; 2020 Jul; 323():519-529. PubMed ID: 32360306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuned Density of Anti-Tissue Factor Antibody Fragment onto siRNA-Loaded Polyion Complex Micelles for Optimizing Targetability into Pancreatic Cancer Cells.
    Min HS; Kim HJ; Ahn J; Naito M; Hayashi K; Toh K; Kim BS; Matsumura Y; Kwon IC; Miyata K; Kataoka K
    Biomacromolecules; 2018 Jun; 19(6):2320-2329. PubMed ID: 29767505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of epirubicin-incorporating micelles tagged with anti-tissue factor antibody clone with no anticoagulant effect.
    Sugaya A; Hyodo I; Koga Y; Yamamoto Y; Takashima H; Sato R; Tsumura R; Furuya F; Yasunaga M; Harada M; Tanaka R; Matsumura Y
    Cancer Sci; 2016 Mar; 107(3):335-40. PubMed ID: 26676840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the antitumor mechanism of antibody-drug conjugates against tissue factor in stroma-rich allograft models.
    Tsumura R; Manabe S; Takashima H; Koga Y; Yasunaga M; Matsumura Y
    Cancer Sci; 2019 Oct; 110(10):3296-3305. PubMed ID: 31348600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin.
    Li X; Ding L; Xu Y; Wang Y; Ping Q
    Int J Pharm; 2009 May; 373(1-2):116-23. PubMed ID: 19429296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A stabilized retro-inverso peptide ligand of transferrin receptor for enhanced liposome-based hepatocellular carcinoma-targeted drug delivery.
    Tang J; Wang Q; Yu Q; Qiu Y; Mei L; Wan D; Wang X; Li M; He Q
    Acta Biomater; 2019 Jan; 83():379-389. PubMed ID: 30395963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transferrin and octaarginine modified dual-functional liposomes with improved cancer cell targeting and enhanced intracellular delivery for the treatment of ovarian cancer.
    Deshpande P; Jhaveri A; Pattni B; Biswas S; Torchilin V
    Drug Deliv; 2018 Nov; 25(1):517-532. PubMed ID: 29433357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of transferrin receptor-targeted liposomal doxorubicin in P-glycoprotein-mediated drug resistant tumor cells.
    Kobayashi T; Ishida T; Okada Y; Ise S; Harashima H; Kiwada H
    Int J Pharm; 2007 Feb; 329(1-2):94-102. PubMed ID: 16997518
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Saavedra-Alonso S; Zapata-Benavides P; Chavez-Escamilla AK; Manilla-Muñoz E; Zamora-Avila DE; Franco-Molina MA; Rodriguez-Padilla C
    Exp Ther Med; 2016 Dec; 12(6):3778-3784. PubMed ID: 28105110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transferrin-conjugated liposome targeting of photosensitizer AlPcS4 to rat bladder carcinoma cells.
    Derycke AS; Kamuhabwa A; Gijsens A; Roskams T; De Vos D; Kasran A; Huwyler J; Missiaen L; de Witte PA
    J Natl Cancer Inst; 2004 Nov; 96(21):1620-30. PubMed ID: 15523091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liposomes bearing polyethyleneglycol-coupled transferrin with intracellular targeting property to the solid tumors in vivo.
    Ishida O; Maruyama K; Tanahashi H; Iwatsuru M; Sasaki K; Eriguchi M; Yanagie H
    Pharm Res; 2001 Jul; 18(7):1042-8. PubMed ID: 11496943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor targeting of doxorubicin by anti-MT1-MMP antibody-modified PEG liposomes.
    Hatakeyama H; Akita H; Ishida E; Hashimoto K; Kobayashi H; Aoki T; Yasuda J; Obata K; Kikuchi H; Ishida T; Kiwada H; Harashima H
    Int J Pharm; 2007 Sep; 342(1-2):194-200. PubMed ID: 17583453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor targeting using anti-her2 immunoliposomes.
    Park JW; Kirpotin DB; Hong K; Shalaby R; Shao Y; Nielsen UB; Marks JD; Papahadjopoulos D; Benz CC
    J Control Release; 2001 Jul; 74(1-3):95-113. PubMed ID: 11489487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of therapeutic effect by using Fab' fragment in the treatment of carcinoembryonic antigen-positive human solid tumors with adriamycin-entrapped immunoliposomes.
    Uyama I; Kumai K; Yasuda T; Tagawa T; Ishibiki K; Kitajima M; Tadakuma T
    Jpn J Cancer Res; 1994 Apr; 85(4):434-40. PubMed ID: 8200855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced antitumor effect of anti-tissue factor antibody-conjugated epirubicin-incorporating micelles in xenograft models.
    Yamamoto Y; Hyodo I; Koga Y; Tsumura R; Sato R; Obonai T; Fuchigami H; Furuya F; Yasunaga M; Harada M; Kato Y; Ohtsu A; Matsumura Y
    Cancer Sci; 2015 May; 106(5):627-34. PubMed ID: 25711681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT).
    Maruyama K; Ishida O; Kasaoka S; Takizawa T; Utoguchi N; Shinohara A; Chiba M; Kobayashi H; Eriguchi M; Yanagie H
    J Control Release; 2004 Aug; 98(2):195-207. PubMed ID: 15262412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted delivery of anticancer drugs to tumor vessels by use of liposomes modified with a peptide identified by phage biopanning with human endothelial progenitor cells.
    Fukuta T; Asai T; Kiyokawa Y; Nakada T; Bessyo-Hirashima K; Fukaya N; Hyodo K; Takase K; Kikuchi H; Oku N
    Int J Pharm; 2017 May; 524(1-2):364-372. PubMed ID: 28359814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted delivery of transferrin and TAT co-modified liposomes encapsulating both paclitaxel and doxorubicin for melanoma.
    Yuan M; Qiu Y; Zhang L; Gao H; He Q
    Drug Deliv; 2016 May; 23(4):1171-83. PubMed ID: 26036724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary delivery of transferrin receptors targeting peptide surface-functionalized liposomes augments the chemotherapeutic effect of quercetin in lung cancer therapy.
    Riaz MK; Zhang X; Wong KH; Chen H; Liu Q; Chen X; Zhang G; Lu A; Yang Z
    Int J Nanomedicine; 2019; 14():2879-2902. PubMed ID: 31118613
    [No Abstract]   [Full Text] [Related]  

  • 20. Antibody targeting of doxorubicin-loaded liposomes suppresses the growth and metastatic spread of established human lung tumor xenografts in severe combined immunodeficient mice.
    Sugano M; Egilmez NK; Yokota SJ; Chen FA; Harding J; Huang SK; Bankert RB
    Cancer Res; 2000 Dec; 60(24):6942-9. PubMed ID: 11156394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.